Sanofi India Ltd. News and Updates

Name: Latest research reports of Sanofi India Ltd. authored by ICICI Direct and published by - Trendlyne research reports.
Item: Sanofi India Ltd.
Rating: 3
Author: ICICI Direct

Keep track of all breaking news on Sanofi India Ltd. from all sources in a single place.

Load latest

Sanofi India Ltd.

27 Jul 2022

6223.00

1.34%

Sanofi India Declares Special Dividend Of Rs 193 Per Equity Share

NDTV Profit

Earlier, the company announced that it has fixed August 8 as the record date for the purpose of payment of the one-time special interim dividend.

Sanofi India Ltd. has gained 24.17% in the last 3 Months

Sanofi India Ltd.

27 Jul 2022

6223.00

1.34%

Sanofi India

Hold: Sanofi India Ltd.

Target

ICICI Direct

Sanofi India Ltd. is trading above all available SMAs

Sanofi India Ltd.

24 Jun 2022

6223.00

1.34%

Sanofi says COVID-19 vaccine candidate yields positive trial data

Moneycontrol

"Sanofi-GSK's vaccine is the first candidate to demonstrate efficacy in a placebo-controlled trial in an environment of high Omicron variant circulation," the firm, which is developing the vaccine jointly with Britain's GSK, said in a statement.

Sanofi India Ltd. has gained 24.17% in the last 3 Months

Sanofi India Ltd.

13 Jun 2022

6223.00

1.34%

Sanofi, GSK say Covid booster shot works better against Omicron variant

Business Standard

The companies point to the risk of new variants and waning immunity that could lead to an increase in demand for additional booster shots in some populations.

Sanofi India Ltd. has lost -27.87% in the last 1 Year

Sanofi India Ltd.

01 Jun 2022, 08:08PM

6223.00

1.34%

Pharma major Sanofi India appoints Preeti Futnani as General Manager, Vaccines

Business Today

Futnani has over two decades of experience in growth and transformation that spans several therapeutic areas and functions within healthcare and finance.

Sanofi India Ltd.'s price crossed above 200Day SMA today

Sanofi India Ltd.

05 May 2022

6223.00

1.34%

Sanofi India: Strong balance sheet, high cash reserves positives for stock

Business Standard

Products in the price control list and growth of the non-power brand portfolio will be key monitorables

Sanofi India Ltd.'s price crossed above 200Day SMA today

Sanofi India Ltd.

29 Apr 2022

6223.00

1.34%

Hold Sanofi India; target of Rs 7740: ICICI Direct

Moneycontrol

ICICI Direct recommended hold rating on Sanofi India with a target price of Rs 7740 in its research report dated April 27, 2022.

Sanofi India Ltd. has lost -27.87% in the last 1 Year

Sanofi India Ltd.

27 Apr 2022

6223.00

1.34%

Buy Sanofi India: target of Rs 9250: Sharekhan

Moneycontrol

Sharekhan is bullish on Sanofi India has recommended buy rating on the stock with a target price of Rs 9250 in its research report dated April 26, 2022.

Sanofi India Ltd. is trading above all available SMAs

Sanofi India Ltd.

27 Apr 2022

6223.00

1.34%

Sanofi India

Hold: Sanofi India Ltd.

ICICI Direct

Abbott India is one of the fastest growing listed MNC pharma companies in women's health, GI, metabolic, pain, CNS among others. We continue to believe in Abbott's strong growth track in power brands and capability in...

Sanofi India Ltd. has gained 24.17% in the last 3 Months

Sanofi India Ltd.

18 Apr 2022

6223.00

1.34%

Sanofi India names Rodolfo Hrosz as new Managing Director

Moneycontrol

Rodolfo Hrosz will transition from being Sanofi's General Manager, Consumer Healthcare business in Brazil to his new role in India as soon as the applicable regulatory approvals are in place, Sanofi India said in a statement.

Sanofi India Ltd. has lost -27.87% in the last 1 Year

Is Sanofi India Ltd. worth buying?

291 Votes:

Buy 79.38%

Sell 11.34%

Hold 9.28%

40.87% Fall from 52W High

Sanofi India Ltd. News and Updates

Keep track of all breaking news on Sanofi India Ltd. from all sources in a single place.